Ascelia Pharma AB
STO:ACE
Ascelia Pharma AB
STO:ACE
Price:
2.985
SEK
-0.67%
Market Closed
Market Cap:
kr378.7m
Balance Sheet
Balance Sheet Decomposition
Ascelia Pharma AB
Ascelia Pharma AB
Balance Sheet Decomposition is not available for
Ascelia Pharma AB
Ascelia Pharma AB
Balance Sheet
Ascelia Pharma AB
Ascelia Pharma AB
Currency: SEK
| Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Cash Equivalents |
109
|
185
|
262
|
150
|
22
|
75
|
50
|
|
| Cash |
109
|
185
|
262
|
150
|
22
|
75
|
50
|
|
| Short-Term Investments |
76
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
1
|
3
|
6
|
5
|
2
|
6
|
3
|
|
| Other Current Assets |
7
|
9
|
7
|
7
|
5
|
3
|
1
|
|
| Total Current Assets |
193
|
196
|
275
|
161
|
29
|
84
|
54
|
|
| PP&E Net |
0
|
2
|
2
|
1
|
1
|
0
|
1
|
|
| PP&E Gross |
0
|
0
|
2
|
1
|
1
|
0
|
0
|
|
| Accumulated Depreciation |
0
|
0
|
2
|
3
|
4
|
5
|
0
|
|
| Intangible Assets |
57
|
57
|
57
|
57
|
57
|
57
|
57
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
250
N/A
|
255
+2%
|
333
+31%
|
219
-34%
|
87
-60%
|
141
+62%
|
112
-21%
|
|
| Liabilities | ||||||||
| Accounts Payable |
5
|
4
|
6
|
16
|
2
|
5
|
2
|
|
| Accrued Liabilities |
7
|
13
|
16
|
20
|
9
|
13
|
8
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
1
|
1
|
0
|
1
|
25
|
1
|
|
| Other Current Liabilities |
1
|
1
|
2
|
2
|
2
|
19
|
1
|
|
| Total Current Liabilities |
13
|
18
|
25
|
38
|
13
|
62
|
12
|
|
| Long-Term Debt |
0
|
1
|
1
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
13
N/A
|
19
+47%
|
26
+33%
|
38
+47%
|
13
-66%
|
62
+386%
|
12
-80%
|
|
| Equity | ||||||||
| Common Stock |
23
|
29
|
35
|
35
|
35
|
97
|
128
|
|
| Retained Earnings |
191
|
286
|
406
|
533
|
640
|
741
|
801
|
|
| Other Equity |
405
|
494
|
679
|
679
|
679
|
723
|
772
|
|
| Total Equity |
237
N/A
|
236
0%
|
308
+30%
|
181
-41%
|
74
-59%
|
79
+6%
|
99
+26%
|
|
| Total Liabilities & Equity |
250
N/A
|
255
+2%
|
333
+31%
|
219
-34%
|
87
-60%
|
141
+62%
|
112
-21%
|
|
| Shares Outstanding | ||||||||
| Common Shares Outstanding |
23
|
28
|
49
|
49
|
50
|
97
|
128
|
|
Switch to:
Switch to:
See Also
Discover More
